Anthropometric and Biochemical Outcomes at follow-up for RAPSID participants allocated to individual, group, combined or control peer support intervention.

*Sample size N refers to the primary outcome HbA1c in the Intention-to-treat population. The per protocol population is in brackets. Range of N for secondary outcomes are as followsControl 240–291 (per protocol 240–291), 1:1 219–270 (141–159), Group 227–273 (174–195), Combined 202–257 (152–184)** Result sensitive to outliers. Conclusion changed after removing outliers more than 4 sd from the mean. Group main effect became −0·70 (95% CI−1·40 to 0·01)§ The model-based ICC for HbA1c at follow-up was calculated to be 0.043 for the primary Intention to treat analysis (including main effects terms only).Anthropometric and Biochemical Outcomes at follow-up for RAPSID participants allocated to individual, group, combined or control peer support intervention.